Francjan Van Spronsen practices in Groningen, Netherlands. Van Spronsen is rated as an Elite expert by MediFind in the treatment of Dihydropteridine Reductase Deficiency. They are also highly rated in 19 other conditions, according to our data. Their top areas of expertise are Phenylketonuria (PKU), Dihydropteridine Reductase Deficiency, Tyrosinemia Type 3, and Tyrosinemia Type 2.
Their clinical research consists of co-authoring 182 peer reviewed articles and participating in 2 clinical trials in the past 15 years. In particular, they have co-authored 99 articles and participated in 2 clinical trials in the study of Dihydropteridine Reductase Deficiency.
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.